A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

NCT05569057 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Cutaneous T-cell Lymphoma (CTCL)

Interventions

DRUG: SIM1811-03

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.